|
J Biol Chem, Vol. 273, Issue 34, 22021-22027, August 21, 1998
Mutant Isolation of the Escherichia coli Quinoprotein
Glucose Dehydrogenase and Analysis of Crucial Residues Asp-730 and
His-775 for Its Function*
Mamoru
Yamada ,
Hisayo
Inbe,
Makoto
Tanaka,
Kenichi
Sumi,
Kazunobu
Matsushita, and
Osao
Adachi
From the Department of Biological Chemistry, Faculty of
Agriculture, Yamaguchi University, Yamaguchi 753-8515, Japan
 |
ABSTRACT |
Several mutants of quinoprotein glucose
dehydrogenase (GDH) in Escherichia coli were obtained and
characterized. Of these, significant mutants were further characterized
by kinetic analysis after purification or by site-directed mutagenesis
to introduce different amino acid substitutions. H775R and H775A showed
a pronounced reduction of affinity for a prosthetic group,
pyrroloquinoline quinone (PQQ), suggesting that His-775 may directly
interact with PQQ. D730N and D730A showed low glucose oxidase activity
without influence on the affinity for PQQ, Mg2+, or
substrate, but D730R showed reduced affinity for PQQ. The spectrum of
tryptophan fluorescence revealed that the local structure surrounding
PQQ was not changed by D730N mutation. Based on these data, we assume
that Asp-730 may occur close to PQQ and function as a proton (and also
electron) donor to PQQ or acceptor from PQQH2.
Substitutions of Gly-689, that are located at the end of a unique
segment of GDH among homologous quinoprotein dehydrogenases, directed
reduction of the affinity for PQQ or GDH activity. Therefore, the
unique segment and Asp-730 may play a specific role for GDH, which
might be related to the intramolecular electron transfer from PQQ to
ubiquinone.
 |
INTRODUCTION |
Quinoprotein GDH1 bound
to the inner membrane in Escherichia coli functions in a
direct oxidation of D-glucose to D-gluconate and concomitantly transferring the electrons to cytochrome oxidase through ubiquinone in the respiratory chain (1, 2). Previous reports
have indicated that GDH possesses the binding sites for PQQ (3, 4),
metal ions such as Mg2+ or Ca2+ (5, 6), and
ubiquinone (1, 8, 9) as well as substrate glucose. The enzyme from
E. coli occurs as the apoenzyme (5) because the organism is
unable to produce PQQ (6), but is readily reconstituted by incubation
with PQQ and the metal ions (7). To elucidate the functional structure,
topological analysis has been performed (10) which revealed that GDH
possesses five membrane-spanning segments at the N-terminal one-sixth
portion, and that the remaining C-terminal five-sixth portion occurs at
the periplasmic side of the membrane. The large C-terminal portion is
assumed to have the catalytic domain including the PQQ-binding site.
The binding site of ubiquinone in GDH has been proposed to be at the
N-terminal hydrophobic domain of the protein (11). The
ubiquinone-binding site has been indicated to be at the region close to
the periplasmic side by using reconstituted proteoliposomes (10), where
no membrane potential is generated by the electron transfer from
glucose to ubiquinone in the dehydrogenase.
Molecular genetic and biochemical analyses of the several quinoprotein
dehydrogenases including glucose, methanol, and alcohol dehydrogenases
have been performed, and their primary sequences are available
(12-19). Their functional structures appear to be different from each
other. Unlike the monomeric and membrane-bound GDH of E. coli (1), Acinetobacter calcoaceticus, or
Gluconobacter oxydans (14, 17-20), the soluble MDH of
Methylobacterium organophilum XX or Paracoccus
denitrificans acts as a tetramer, 2 2, to transfer electrons
to cytochrome c (13, 21, 22). Whereas, membrane-bound ADH of
Acetobacter aceti occurs as a trimer,   , to transfer electrons via intramolecular heme c moieties to ubiquinone
(23). Alignment of the PQQ-binding protein or subunit in these
dehydrogenases revealed that they have three homologous regions
including the highly conserved region consisting of about 70 amino acid
sequences at their C termini (20), which had been predicted as a common PQQ-binding site (16, 17). Therefore, the structure of the catalytic
proteins of quinoprotein dehydrogenases may be partially similar to
each other, but they transfer electrons to different components.
Recently, three-dimensional structures of MDHs from three different
sources of Methylophilus methylotrophus, Methylophilus W3A1,
and Methylobacterium extorquens AM1 (24-26) have been
determined, revealing that the amino acid residues interacting with PQQ
and Ca2+ are dispersed in the whole -subunit, which
forms a superbarrel structure made up of eight topologically identical
four-stranded antiparallel -sheets. On the basis of the structure, a
model structure of GDH was proposed except for its N terminus and
several unique segments that are absent in MDH of M. extorquens (27). However, neither direct evidence supporting the
structure nor x-ray crystallography has been reported yet.
In order to identify amino acid residues crucial for GDH function, we
introduced random mutagenesis that may be useful for structurally
unknown enzyme. A single protein GDH is a good model to elucidate the
molecular mechanism of catalytic reaction or intramolecular electron
transfer of the primary dehydrogenase in the respiratory chain. This is
the first report on GDH mutant isolation and characterization except
for one that showed a mutant with little effect on the activity (28).
We obtained several E. coli mutant GDHs, and then
characterized them in respect to their glucose dehydrogenase,
ubiquinone reductase, and glucose oxidase activities. Mutant GDHs with
a pronounced effect on the enzyme activities were purified and their
kinetic parameters were determined. The mutation effect of some mutants
were further examined by introducing different amino acid
substitutions. We identified at least two crucial residues, Asp-730 and
His-775, possibly related to proton transfer and to binding to PQQ,
respectively, to which no corresponding residue was proposed in the GDH
model (27).
 |
EXPERIMENTAL PROCEDURES |
Materials--
Restriction enzymes, T4 DNA ligase,
Taq DNA polymerase, and the DNA sequencing kit were
purchased from Takara Shuzo (Kyoto, Japan). Oligonucleotide primers
were made by ourselves on a DNA synthesizer, Gene Assembler Plus
(Pharmasia, Uppsala, Sweden) or by Sawady Technology (Tokyo, Japan).
All other chemicals were of analytical grade.
Bacterial Strains and Plasmids--
The bacterial strains used
in this study were all derivatives of E. coli K12. Their
relevant genotypes and plasmids are shown in Table I. Mutations
gcd::cm, insertion of the cm
gene into the gcd gene encoding GDH, and pts,
lacking the ptsHI, from YU124 and LJ288, respectively, were
transferred into W3110 by P1 transduction (32). The resulting YU245 was
still able to grow on M9 glucose minimal medium (32). Thus, after
N-methyl-N'-nitro-N-nitrosoguanidine mutagenesis (32) of YU245 and penicillin screening (33), YU312 that
grew very slowly on the M9 glucose medium was isolated and used for
screening gcd mutants. YU312 exhibited weak red colonies on
tetrazolium plates (32) containing glucose and PQQ. While, YU312 cells
harboring pACGCD1 or -2, which bears the gcd gene as
described below, showed white colonies on the plates.
Subcloning the gcd Gene into a Low Copy Plasmid--
To
certainly obtain gcd mutants, the gcd gene on a
high copy plasmid, pUCGCD1 (19), was subcloned into a low copy plasmid of a pACYC177 derivative, pACYC177-322, in which the large
BamHI-PstI fragment of pACYC177 had been
connected with the small BamHI-PstI fragment of
pBR322. The EcoRI-PstI fragment bearing the
gcd gene from pUCGCD1 was inserted into the
EcoRI-PstI site of pACYC177-322, generating
pACGCD1. The DraI-PstI fragment bearing the
gcd gene from pUCGCD1 was inserted into the
HincII-PstI site of pUC118. From the resulting
pUCGCD2, the EcoRI-PstI fragment bearing the gcd gene was inserted into the
EcoRI-PstI site of pACYC177-322, generating
pACGCD2. The gcd gene on pACGCD1 is about 200 base pairs
larger at the 5'-upstream noncoding region than that on pACGCD2. We
used these two plasmids for different mutagenesis because they have
different restriction sites at the 5'-upstream region. After
mutagenesis, each mutated region of the gcd gene was
replaced into the wild type gcd gene of pUCGCD1 to
facilitate enzyme assay.
Mutagenesis--
To mutagenize the conserved C terminus from the
734th to 796th amino acid in GDH, region-specific PCR mutagenesis was
performed with two primers, 5'-TTGCATGCCTGCAGGTC-3' and
5'-TTGGATCCAACAGGGTACGCTGGTC-3' in an 0.5-ml microcentrifuge tube in a
final volume of 100 µl in which 0.1 nM pUCGCD1, a dNTP
mixture (125 µM each of dATP, dTTP, and dGTP, and 12.5 µM dCTP, or 125 µM each of dATP, dCTP and
dGTP, and 12.5 µM dTTP), 100 pmol of each oligonucleotide primer, and 2.5 units of Taq DNA polymerase were added in 10 mM Tris-HCl, pH 8.3, 50 mM KCl, 0.5 mM MnCl2, 1.5 mM MgCl2,
and 0.001% gelatin (w/v). Twenty-five polymerase chain reactions, each
of which consisted of denaturation at 94 °C for 1 min, annealing at
55 °C for 2 min, and extension at 72 °C for 2 min, were carried out by a DNA Thermal Cycler, PJ2000 (Perkin-Elmer) as described (10).
The PCR products were electrophoresed by Sea-plaque gels (Takara Shuzo)
and recovered by ethanol precipitation after extraction from the gel
and phenol extraction. The PCR fragments were then digested with
BssHII and PstI, and inserted into the
BssHII-PstI site of pACGCD2.
To mutagenize the whole region of gcd encoding GDH, in
vitro mutagenesis with hydroxylamine was carried out as described
(34). DNA solution (100 µl) of pACGCD1 (10 µg) in 20 mM
Tris-HCl, pH 7.5, containing 1 mM EDTA was mixed with 200 µl of 0.6 M NH2OH in 40 mM
K2HPO4 and 1 mM EDTA, and then
incubated overnight at 37 °C. The materials were then dialyzed three
times against 10 mM Tris-HCl, pH 7.5, containing 1 mM EDTA and recovered by ethanol precipitation. The plasmid
DNA was used as a mutagenized DNA for transformation.
Screening of the gcd Mutants--
Mutagenized plasmid DNA was
introduced into YU312, and weak red color colonies on tetrazolium
plates (32) containing 0.5% glucose, 0.1 µM PQQ, and 50 µg/ml kanamycin were isolated as the gcd mutant. To avoid
mutants producing immature GDHs, the isolates were then examined by
Western blot using an antibody raised against GDH as described
previously (35) and by measurement of GDH activity.
DNA Manipulations and Sequencing--
Conventional recombinant
DNA techniques (36) were used. To determine the mutation sites,
nucleotide sequencing was carried out by the dideoxy chain termination
method (37) after subcloning DNA fragments into M13 mp18 or mp19 vector
(38) or with the Thermo Sequenase cycle sequencing kit (Amersham,
Brucks, United Kingdom). To determine the region including the mutation
site of the mutants from hydroxylamine mutagenesis, recombination
between the mutant gcd genes and the wild type
gcd gene was performed. When the
SalI-PstI fragment of the wild type
gcd gene encoding the C-terminal five-sixth portion of the
enzyme was replaced by corresponding mutant fragments, all recombinants
showed the mutant phenotype. Further recombination experiments using
two fragments produced from the SalI-PstI
fragment by SmaI digestion indicated that two of them have
mutation sites between the SalI and SmaI sites
and the other two have between the SmaI and PstI
sites. These limited regions were then subjected to nucleotide
sequencing.
Site-specific Mutagenesis--
To obtain mutants, R687A, R687D,
G689A, D693A, D730A, D730R, and H775A, site-specific mutagenesis was
carried out using the Mutan-Super Express Km kit (Takara Shuzo).
Mutagenic primers used: 5'-TGGAAGAAAGCTATTGGTAC-3'for R687A;
5'-TGGAAGAAAGATATTGGTAC-3' for R687D; 5'-AACGTATTGCTACGCCGCAG-3' for
G689A; 5'-CGCCGCAGGCCAGTATGCCG-3' for D693A; 5'-GCTACGGCAGCTAACTACCT-3'
for D730A; 5'-GCTACGGCACGTAACTACCT-3' for D730R; and
5'-GCAGGCGGTGCCGGTTCATT-3' for H775A. Introduced mutations were
confirmed by nucleotide sequencing.
Enzyme Assay and Analytical Procedures--
Cells harboring wild
type plasmid, pUCGCD1, or mutant plasmids, pUCGCDs, were grown in LB
(1% Bacto-tryptone, 0.5% yeast extract, and 0.5% NaCl) containing
ampicillin (100 µg/ml) for 14 h at 37 °C, harvested, and
washed twice with 0.85% NaCl. The cells were then disrupted by passing
twice through a French pressure cell press (16,000 p.s.i.). After
removing unbroken cells by a low speed centrifuge, membrane fractions
were recovered by centrifugation at 86,000 × g for 90 min. The membrane was suspended in 100 mM Tris-HCl, pH 7.0 (about 10 mg of protein/ml), for enzyme assay. PMS and Q-1 reductase
activities of GDH, and glucose oxidase activity were measured as
described previously (8, 10). Dehydrogenase (PMS reductase) activity
was also measured with maltose, fucose, galactose, or xylose, instead
of glucose, as a substrate as described previously (39). Succinate
dehydrogenase (PMS reductase) activity was measured as a control by the
same assay method used for GDH except that PQQ was omitted. Kinetic
parameters were estimated from the Lineweaver-Burk plot drawn by using
the program EnzymeKinetics (Trinity Software Technical Support, NH).
Protein content was determined according to the Dulley and Grieve
method (40) using bovine serum albumin as a standard. Fluorescence
spectra were taken by using a Hitachi-650-10S of 1-ml samples (0.4 µM in enzyme) in 100 mM potassium phosphate,
pH 7.0, containing 0.2% -octylgluoside and 3 mM
MgCl2 in the presence or absence of 1.5 µM
PQQ. Fluorescence emission was scanned from 290 to 460 nm at 25 °C
with an excitation at 280 nm.
Purification of Mutant GDHs--
Four mutant GDHs with
significant effect on the enzyme activity were purified according to
the procedure as described previously (10). In S357L and G689D, all
purification steps were performed in the presence of 10 nM
PQQ to stabilize enzyme activity. Purified mutant proteins as well as
wild type were analyzed by SDS-10% polyacrylamide gel electrophoresis,
revealing that their purity was more than 95% homogeneity. To take
fluorescence spectra, the purified protein was readsorbed to DEAE
column equilibrated with 10 mM potassium phosphate, pH 7.0, containing 0.1% Triton X-100, and after washing with the same buffer
in the absence of Triton, the enzyme was eluted with the same buffer
containing 0.2% -octylgluoside.
 |
RESULTS AND DISCUSSION |
Isolation of the gcd Mutants--
Out of 30 Gcd
mutants isolated from region-specific mutagenesis, targeting the
conserved C terminus of GDH, four were found to exhibit less than 10%
PMS reductase activity of the wild type. In the mutant plasmids,
pACGCD2Ms, from the four mutants, the BssHII-PstI
fragments corresponding to those prepared by the PCR mutagenesis were
sequenced. Three of them were found to have a single mutation in the
region and the remaining one has double, and all mutations except for
one of the double mutants occurred at the conserved amino acid residues
among GDHs of E. coli, A. calcoaceticus, and G. oxydans (Table I). Of these mutants,
three mutant GDHs from pACGCD2M9, M13, and M15 were detected by Western blot analysis using an antibody against E. coli GDH but not
one from pACGCD2M5 (data not shown). pACGCD2M5 has a nonsense mutation at the 765th codon in the gcd gene, resulting in producing
an immature GDH presumably susceptible to intracellular proteolytic degradation. The mutated protein from pACGCD2M9 is expected to have an
extra 18 amino acid residues because of mutation of the intrinsic stop
codon, which was indicated as a slightly slow migration in
SDS-polyacrylamide gel electrophoresis.
Out of 32 Gcd mutants isolated from hydroxylamine
mutagenesis, four had less than 10% PMS reductase activity of the wild
type. These mutants were also analyzed by Western blot to confirm
producing GDH protein. To limit the region including mutation sites,
recombination between the mutant gcd genes and the wild type
gcd gene was performed as described under "Experimental
Procedures," and the limited regions were sequenced. All mutations of
the four mutants, pACGCD1N2, -3, -4, or -7, are G to A or C to T as
shown in Table I, suggesting that they are derived from the
hydroxylamine treatment, and all mutations occurred at conserved amino
acid residues among GDHs of the three organisms.
Enzyme Activities of Mutant GDHs--
To compare the mutant GDHs
with the wild type, activities of PMS reductase, Q-1 reductase, and
glucose oxidase were measured with the membrane fractions (Table
II). Relative GDH protein contents in the
fractions were estimated by Western blot analysis (Fig. 2), and then
relative PMS reductase activity was calculated based on the relative
GDH contents. The results revealed that all mutant GDHs have PMS
reductase activity less than 10% of the wild type, with comparable Q-1
reductase and glucose oxidase activities except for G741S and -797K
(where - means a stop codon). The latter two mutant GDHs seem to retain
equivalent activities of PMS reductase and glucose oxidase to those of
the wild type, so their apparent reduced activities may be due to lower
content of GDH in the membrane than that of the wild type. The mutant
-797K reduced Q-1 reductase activity without the significant effect on
Km values for PQQ and Mg2+ or on glucose
oxidase activity, which reflects the normal electron transfer from GDH
via intrinsic Q-8 to cytochrome oxidase. Thus, it seems that the
additional C-terminal 18 amino acid residues of the mutant GDH may
hamper access of the artificial Q-1, or change the conformation of the
Q-1 reacting site but not of the Q-8 reacting site.
View this table:
[in this window]
[in a new window]
|
Table II
PMS reductase, Q-1 reductase, and glucose oxidase activities of mutant
GDHs in the membrane fractions and their kinetic properties
PMS reductase activity was measured in the presence of 33 mM glucose, 1 mM MgCl2, 0.5 µM PQQ, and 8 mM NaN3. For
E742G/P757L, G689D, and H775R mutants, PQQ was added at a final
concentration of 1.5 µM except that 30 µM
was used for H775R. The preincubation requiring for holo-enzyme
formation was performed at 25 °C for 20 min. Kinetic parameters were
estimated by measuring PMS reductase activity. Ubiquinone reductase
activity was measured at 25 °C by the addition of both 10 mM glucose and 50 µM Q-1 after 20-min
preincubation in the presence of 1 µM PQQ and 1 mM MgCl2. Glucose oxidase activity was measured at
25 °C by the addition of 30 mM glucose after 20-min
preincubation in the presence of 1 µM PQQ and 1 mM MgCl2. For G689D and H775R, PQQ was added at a
final concentration of 2 and 30 µM, respectively.
Reported values are the averages of two to three independent
experiments performed in triplicate.
|
|
Kinetic Parameters of Mutant GDHs--
To define characteristics
of the mutant GDHs, their kinetic parameters were compared with those
of the wild type in the membrane fractions (Table II). S357L, G689D,
and H775R showed significantly increased Km values
for PQQ, and especially, H775R had 230-fold higher
Km values for PQQ than wild type. P326L, G689D,
G741S, and the double mutant E742G/P757L showed slightly higher
Km values for Mg2+. All showed nearly
the same Km value for glucose as that of wild type,
indicating that no mutant appears to be affected at the
substrate-binding site. Since GDH has some activities for fucose,
galactose, xylose, mannose, and maltose (39), substrate specificity of
the mutant GDHs was tested but no mutant showed different substrate
specificity from the wild type (data not shown). Therefore, it is
likely that no mutation occurs in amino acid residues related to the
substrate binding, and that the mutations in these mutant GDHs may not
cause total conformational changes of the protein.
Of those, four significant and intriguing mutant GDHs were subjected to
purification for further characterization, in which S357L, G689D, and
H775R showed much lower affinity for PQQ and D730N had reduced
activities of PMS reductase and glucose oxidase but normal affinities
for PQQ, Mg2+, and glucose. Both S357L and G689D were
purified only when PQQ was added to solutions used in purification
steps, suggesting that Ser-357 and Gly-689 are located near the
PQQ-binding site and both mutations lead to a release of PQQ from the
enzyme which may cause deleterious conformational change of GDH during
purification. Whereas, the other two mutant GDHs could be purified in
homogeneity under the condition without PQQ like the wild type. The
kinetic parameters of the purified GDHs were found to be essentially
the same as those obtained with the membrane fractions (Tables II and
III). All four purified mutant GDHs
showed Vmax less than 5% of the wild type and
equivalent affinities for glucose and Mg2+ to those of the
wild type, and all except for D730N were confirmed to have reduced
affinity for PQQ. We thus tried to compare these mutation positions
with the amino acid residues surrounding PQQ or Ca2+ in the
superbarrel structure of a model GDH, which was proposed by Cozier and
Anthony (27) based on the x-ray structure of the M. extorquens MDH, as follows. The model structure is formed with eight W-shaped domains consisting of four antiparallel -sheets and
has loops a to g, of which some are specific for GDH or distinct from
MDH.
View this table:
[in this window]
[in a new window]
|
Table III
Kinetic properties of purified mutant GDHs
Kinetic parameters were estimated in the presence of 33 mM
glucose, 1 mM MgCl2, 0.5 µM PQQ, and
8 mM NaN3 except for material whose parameter was
estimated. For mutants S357L, G689D, and H775R, PQQ was added at a
final concentration of 1.5, 1.5, and 30 µM, respectively.
The preincubation required for holo-enzyme formation was performed at
25 °C for 20 min.
|
|
Mutations Influencing on Affinity for PQQ--
Among the mutant
GDHs, the altered amino acid residues of S357L and H775R are located
close to the active site in the model. The S357L mutation influenced
the affinity for PQQ but not for Mg2+, although Thr-353
beside Ser-357 hydrogen bonds to PQQ, and Asp-354 and Asn-355 to
Ca2+ in the model. From these results and the evidence that
S357L purification required the addition of PQQ, it is suggested that the Ser to Leu mutation in S357L may cause a local structural change
and also influence the position of Thr-353 to reduce affinity for
PQQ.
H775R showed an extremely reduced affinity for PQQ and low
Vmax. To test whether there is a side effect by
the alteration from His to Arg or not, we constructed a mutant H775A
with substitution of a relatively small residue (Table
IV, Fig. 3). The mutant also showed a low
affinity for PQQ, but had an equivalent PMS reductase activity to that
of the wild type. These results suggest that His-775 may directly
interact with PQQ and that the Arg mutation but not the Ala mutation
may disturb the conformation of the active site to decrease the
turnover. We assume that His-775 hydrogen bonds to the C2 carboxyl
group of PQQ instead of Ser-777 proposed in the model and the His-775
substitution with Arg or Ala gave rise to reduction in the affinity for
PQQ. Alternatively, the substitutions may move the position of Ser-777
to weaken its hydrogen bond to PQQ.
View this table:
[in this window]
[in a new window]
|
Table IV
Properties of the mutant GDHs produced by site-directed mutagenesis
Km values for PQQ of the mutant GDHs were estimated
in the presence of 33 mM glucose, 1 mM
MgCl2, 8 mM NaN3. The preincubation for
holo-enzyme formation was performed at 25 °C for 20 min. Reported
values are the averages of two independent experiments performed in
triplicate.
|
|
Notably, Cleton-Jansen et al. (18) have reported that in the
G. oxydans GDH, the Asn mutation from the conserved His,
corresponding to His-775 in E. coli GDH, changed the
substrate specificity from glucose to maltose. In the model, His-775
approaches PQQ in the active site, and the replacement of His-775 by
Asn was proposed to form a more accessible active site through the
funnel (27). Our experiments revealed that the Km
values for maltose of H775R and H775A were 150 and 53 mM,
respectively, which were slightly lower than that of the wild type GDH,
being 250 mM, although their Km values
for glucose were nearly the same as that of the wild type. Therefore,
His-775 as proposed may be exposed to the funnel and the discrepancy
between the mutants of G. oxydans and E. coli
might be due to difference of the substituted residues or of residues
around the His residue in each tertiary structure.
To examine the effect of the G689D mutation on affinity for PQQ, a
mutant G689A was constructed and characterized (Table IV, Fig. 3). The
affinity of G689A was similar to that of wild type although its PMS
reductase activity was lower than that of wild type. Gly residues often
form restrictive bond angles, so that the Gly substitution with other
amino acid residues may perturb the local structure and adjacent
residues that may have a functional role will be moved. Thus, assuming
that a residue(s) close to Gly-689 may be involved in binding to PQQ,
we targeted two conserved charged amino acid residues, Arg-687 and
Asp-693, near Gly-689 to construct three mutants, R687A, R687D, and
D693A. The former two mutant proteins were found to be low in membrane
fractions and seems to be unstable. The amount of both proteins were 20 times less than that of the wild type even when the membrane fractions were prepared in the presence of PQQ and immediately subjected to
electrophoresis for Western blot analysis. They could not be detected
after one freeze-thaw treatment (Fig. 3 and data not shown). Because
Arg-687 occurs on the outer -sheet, D-strand, of W6 -sheets (27)
and its substitutions seemed to enhance degradation of GDH, the residue
is assumed to stabilize the superbarrel structure presumably via ionic
interaction to a residue on another -sheet. These mutation effects
appear to be different from that of G689D or G689A because G689D in the
presence of PQQ and G689A even in the absence were stable. D693A showed
no effect on affinity for PQQ and on relative PMS reductase activity.
Therefore, although we cannot exclude the possibility that around
Gly-689 there are specific residue(s) interacting with PQQ or
contributing to catalytic function, these data together with those of
G698D and G689A suggest that the substituted Asp residue of G689D
caused reduction of the affinity for PQQ presumably by changing the
confomation around the PQQ-binding site, and that the Gly-689 in the
wild type would give a crucial local structure around the residue.
Notably, in the model, Gly-689 is located beside the D-strand of W6 and
at the end of loop e, most of which is conserved in GDHs but absent in
MDHs or ADH (Ref. 27 and see Fig. 1), so
that the loop e might be important for PQQ binding in GDH.

View larger version (53K):
[in this window]
[in a new window]
|
Fig. 1.
Alignment of the C-terminal amino acid
sequences of quinoprotein dehydrogenases and mutation positions of some
mutant GDHs. ECO-GDH (19), ACA-GDH (14), and GOX-GDH (18) are GDHs
in E. coli, A. calcoaceticus, and G. oxydans, respectively, and MEX-MDH (27) is MDH in M. extorquens. This alignment and some structural features were shown
according to Ref. 27. Only C-terminal alignment is presented and
protein residue numbers were shown next to the protein names.
Asterisks show identical residues between the sequences of
GDH in E. coli and MDH in M. extorquens. Mutation
sites of three mutant GDHs obtained here are shown by
boxes.
|
|
As for the mutation sites of the other three mutants, P326L, G741S, and
E742G/P757L, there are no corresponding amino acid residues interacting
with PQQ or Mg2+ in the model. Pro-326 occurs in the loop f
of the model which is absent from MDH and P326L influenced on affinity
for Mg2+ more than other mutants (Table II). Therefore, it
is possible that loop f positions near the Mg2+-binding
site. The mutation sites of G741S and E742G/P757L are located at the
C-terminal region highly conserved in the quinoprotein dehydrogenase
family, and Gly-741 and Glu-742 occur in the D-strand of W7.At the
C-terminal region of the model, there are 11/2 -sheet W
motifs with a tryptophan docking motif, but with respect to such a
conservation, no specific function has been proposed, except dimerization in the case of MDH (27). Both mutations as well as -797K,
which has the longer C terminus that may disturb the W8 structure,
reduced the content of the mutant proteins in the membrane fractions
(Fig. 2 and Table II), suggesting that
the conserved region is crucial for stability of the enzyme structure. This region might also provide the interaction site for the possible N-terminal ubiquinone-binding domain in GDH or an unknown factor supporting GDH stability.

View larger version (63K):
[in this window]
[in a new window]
|
Fig. 2.
Western blot analysis of the mutant GDHs
obtained by region-specific and hydroxylamine mutageneses. The
membrane fractions from YU312 containing pUCGCD1, pUC118, or pUCGCD
mutants that were used for estimating various enzyme activities as
shown in Table II were subjected to a SDS-10% polyacrylamide gel
electrophoresis, and transferred to the blot membrane. YU312 cells
containing pUCGCD1 or pUC118 were used as a positive and negative
control, respectively. The wild type and mutant GDHs (GDH)
were visualized using a polyclonal antibody against E. coli
GDH as described previously (10). The relative amounts of the proteins
were densitometrically estimated by using BIO-RAD Molecular Imager.
Lanes 2-7 and 9-14 represent the membrane
fractions from the positive control (wild type, 2.0 µg), the positive
control (1.0 µg), G741S (12 µg), -797K (60 µg), H775R (2.0 µg),
the double mutant of E742G/P757L (60 µg), the positive control (1.0 µg), the negative control (60 µg), G689D (2.0 µg), S357L (2.0 µg), D730N (2.0 µg), and P326L (2.0 µg), respectively.
Lanes 1 and 8 are prestained markers,
phosphorylase b (105,000) and bovine serum albumin (70, 800).
|
|
Possible Function of Asp-730--
D730N showed significantly
decreased activities of PMS reductase, Q-1 reductase, and glucose
oxidase, but no effect on affinity for PQQ or Mg2+ (Tables
II and III). The substitution from Asp to Asn does not seem to cause a
large conformational change. To further analyze the function of
Asp-730, two mutants, D730A and D730R, were constructed and
characterized with membrane fractions (Table IV, Fig.
3). Both mutants also showed low PMS
reductase activities comparable to D730N.

View larger version (62K):
[in this window]
[in a new window]
|
Fig. 3.
Western blot analysis of the mutant GDHs
obtained by site-specific mutagenesis and their stability in membrane
fractions. The membrane fractions from YU312 containing pUCGCD1,
pUC118, or pUCGCD mutants were used. Gel electrophoresis, blotting, and
visualization were done as shown in Fig. 2. A, the mutant
GDHs from site-specific mutagenesis in membrane fractions were analyzed
after one freeze-thaw treatment. Lanes 1-10 represent the
membrane fractions (1 µg) from the positive control (wild type) and
negative control, R687A, R687D, D730A, D730R, H775A, G689A, D693A, and
the positive control, respectively. B, R687A,
R687D, and the wild type GDHs in membrane fractions which were freshly
prepared in the presence or absence of 10 nM PQQ were
analyzed. Lanes 1-6 represent the membrane fractions from
the wild type (1 µg), the wild type (+ PQQ, 1 µg), R687A (10 µg),
R687A (+ PQQ, 10 µg), R687D (10 µg), and R687D (+ PQQ, 10 µg),
respectively. Lanes M are prestained markers.
|
|
In contrast to D730N and D730A, Km for PQQ was
increased in D730R. Thus, to define whether or not the D730N mutation affects the local structure around the PQQ-binding site, we examined the local conformational change by measuring quenching of intrinsic tryptophan fluorescence induced by addition of PQQ (data not shown). Both purified apo-GDHs of D730N and the wild type exhibited the same
fluorescence spectrum with an emission maximum at 338 nm when excited
at 280 nm. Both fluorescence were similarly quenched by the addition of
PQQ, and the quenching ratio with PQQ was similar. These results
suggest that the Asp to Asn substitution at position 730 may not change
the local conformation surrounding PQQ but the Arg substitution may
influence the structure around the PQQ-binding site to reduce the
affinity for PQQ. Asp-730 may thus be located close to the PQQ-binding
site, although it occurs between -sheet structures in W7 of the
model. Although the large difference in conformational effect was
observed among Asp-730 mutants, all of them exhibited largely decreased
PMS reductase activity, suggesting that Asp-730 may have a catalytic
function. From these results, we assume that Asp-730 may position close
to the catalytic site and is involved in proton (electron) donation to
PQQ or proton extraction from PQQH2.
GDH transfers electrons directly to ubiquinone, while MDH to cytochrome
c (20), and ADH to the intramolecular heme c
(23), although they are proposed to share a central superbarrel
structure (26, 27). They appear to have a similar configuration
surrounding PQQ and the divalent cation to each other, but to evolve
different segments or residues specific for the intramolecular electron transfer to the specific electron acceptor. Therefore, GDH has unique
segments within the basic superbarrel structure and especially, a
segment loop e in the model conserved among GDHs occurs between the
conserved tryptophan docking motifs W6 and W7, where Gly-689 is
located. Around loop e in the tertiary structure there is a functionally important and conserved residue, Asp-730. Thus, the residue and loop e might play a specific role for GDH from catalytic reaction to electron transfer to ubiquinone.
 |
ACKNOWLEDGEMENTS |
We thank Drs. M. Tuda and M. H. Saier,
Jr. for providing bacterial strains. We also thank M. Maeyama for
technical assistance.
 |
FOOTNOTES |
*
This work was supported in part by a Grant-in Aid from the
Ministry of Education, Science and Culture of Japan.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Biological
Chemistry, Faculty of Agriculture, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, Japan. Tel.: 81-839-33-5869; Fax: 81-839-33-5820; E-mail: yamada{at}agr.yamaguchi-u.ac.jp.
The abbreviations used are:
GDH, glucose
dehydrogenase; MDH, methanol dehydrogenase; ADH, quinohaemoprotein-cytochrome c alcohol dehydrogenaseQ-1, ubiquinone-1Q-8, ubiquinone-8PCR, polymerase chain reactionPQQ, pyrroloquinoline quinonePMS, phenazine methosulfate.
 |
REFERENCES |
-
Matsushita, K.,
Nonobe, M.,
Shinagawa, E.,
Adachi, O.,
and Ameyama, M.
(1987)
J. Bacteriol.
169,
205-209[Abstract/Free Full Text]
-
Van Schie, B. J.,
Hellingwerf, K. J.,
van Dijken, J. P.,
Elferink, M. G. L.,
van Dijl, J. M.,
Kuenen, J. G.,
and Konings, W. N.
(1985)
J. Bacteriol.
163,
493-499[Abstract/Free Full Text]
-
Duine, J. A.,
Frank, J.,
and van Zeeland, J. K.
(1979)
FEBS Lett.
108,
443-446[CrossRef][Medline]
[Order article via Infotrieve]
-
Ameyama, M.,
Matsushita, K.,
Ohno, Y.,
Shinagawa, E.,
and Adachi, O.
(1981)
FEBS Lett.
130,
179-183[CrossRef][Medline]
[Order article via Infotrieve]
-
Hommes, R. W. J.,
Postma, P. W.,
Neijssel, O. M.,
Tempest, D. W.,
Dokter, P.,
and Duine, J. A.
(1984)
FEMS Microbiol. Lett.
24,
329-333[CrossRef]
-
Matsushita, K.,
Arents, J. C.,
Bader, R.,
Yamada, M.,
Adachi, O.,
and Postma, P. W.
(1997)
Microbiology
143,
3149-3156[Abstract/Free Full Text]
-
Ameyama, M.,
Nonobe, M.,
Hayashi, M.,
Shinagawa, E.,
Matsushita, K.,
and Adachi, O.
(1985)
Agric. Biol. Chem.
49,
1227-1231
-
Matsushita, K.,
Shinagawa, E.,
Adachi, O.,
and Ameyama, M.
(1989)
J. Biochem. (Tokyo)
105,
633-637[Abstract/Free Full Text]
-
Matsushita, K.,
Shinagawa, E.,
Adachi, O.,
and Ameyama, M.
(1989)
Biochemistry
28,
6276-6280[CrossRef][Medline]
[Order article via Infotrieve]
-
Yamada, M.,
Sumi, K.,
Matsushita, K.,
Adachi, O.,
and Yamada, Y.
(1993)
J. Biol. Chem.
268,
12812-12817[Abstract/Free Full Text]
-
Friedrich, T.,
Strohdeicher, M.,
Hofhaus, G.,
Preis, D.,
Sahm, H.,
and Weiss, H.
(1990)
FEBS Lett.
265,
37-40[CrossRef][Medline]
[Order article via Infotrieve]
-
Harms, N.,
de Vries, G. E.,
Maurer, K.,
Hoogendijk, J.,
and Stouthamer, A. H.
(1987)
J. Bacteriol.
169,
3969-3975[Abstract/Free Full Text]
-
Machlin, S. M.,
and Hanson, R. S.
(1988)
J. Bacteriol.
170,
4739-4747[Abstract/Free Full Text]
-
Cleton-Jansen, A.-M.,
Goosen, N.,
Odle, G.,
and Van de Putte, P.
(1988)
Nucleic Acids Res.
16,
6228[Free Full Text]
-
Cleton-Jansen, A.-M.,
Goosen, N.,
Vink, K.,
and van de Putte, P.
(1989)
Mol. Gen. Genet.
217,
430-436[CrossRef][Medline]
[Order article via Infotrieve]
-
Inoue, T.,
Sunagawa, M.,
Mori, A.,
Imai, C.,
Fukuda, M.,
Tagaki, M.,
and Yano, K.
(1989)
J. Bacteriol.
171,
3115-3122[Abstract/Free Full Text]
-
Cleton-Jansen, A.-M.,
Goosen, N.,
Fayet, O.,
and van de Putte, P.
(1990)
J. Bacteriol.
172,
6308-6315[Abstract/Free Full Text]
-
Cleton-Jansen, A.-M.,
Dekker, S.,
van de Putte, P.,
and Goosen, N.
(1991)
Mol. Gen. Genet.
229,
206-212[CrossRef][Medline]
[Order article via Infotrieve]
-
Yamada, M.,
Asaoka, S.,
Saier, M. H., Jr.,
and Yamada, Y.
(1993)
J. Bacteriol.
175,
568-571[Abstract/Free Full Text]
-
Anthony, C.
(1992)
Int. J. Biochem.
24,
29-39[CrossRef][Medline]
[Order article via Infotrieve]
-
Anthony, C.,
Chan, H. T. C.,
Cox, J. M.,
and Richardson, I. W.
(1993)
in
Microbial Growth on C1 Compounds (Murrell, J. C., and Kelly, D. P., eds), pp. 221-233, Intercept Ltd., Andover, United Kingdom
-
Van Spanning, R. J. M.,
Wansell, C. W.,
De Boer, T.,
Hazelaar, M. J.,
Anazawa, H.,
Harms, N.,
Oltmann, L. F.,
and Stouthamer, A. H.
(1991)
J. Bacteriol.
173,
6948-6961[Abstract/Free Full Text]
-
Matsushita, K.,
Yakushi, T.,
Toyama, H.,
Shinagawa, E.,
and Adachi, O.
(1996)
J. Biol. Chem.
271,
4850-4857[Abstract/Free Full Text]
-
Xia, Z.-X.,
Dai, W.-W.,
Xiong, J.-P.,
Hao, Z.-P.,
Davidson, V. L.,
White, S.,
and Mathews, F. S.
(1992)
J. Biol. Chem.
267,
22289-22297[Abstract/Free Full Text]
-
White, S.,
Boyd, G.,
Mathews, F. S.,
Xia, Z.-X.,
Dai, W.-W.,
Zhang, Y.-F.,
and Davidson, V. L.
(1993)
Biochemistry
32,
12955-12958[CrossRef][Medline]
[Order article via Infotrieve]
-
Blake, C. C. F.,
Ghosh, M.,
Harlos, K.,
Avezoux, A.,
and Anthony, C.
(1994)
Nat. Struct. Biol.
1,
102-105[CrossRef][Medline]
[Order article via Infotrieve]
-
Cozier, G. E.,
and Anthony, C.
(1995)
Biochem. J.
312,
679-685
-
Sode, K.,
and Sano, H.
(1994)
Biotechnol. Lett.
16,
455-460
-
Bolivar, F.,
Rodriquez, R. L.,
Greene, P. J.,
Betlach, M. C.,
Heyneker, H. L.,
and Boyer, H. W.
(1977)
Gene (Amst.)
2,
95-113[Medline]
[Order article via Infotrieve]
-
Chang, A. C. Y.,
and Cohen, S. N.
(1978)
J. Bacteriol.
134,
1141-1156[Abstract/Free Full Text]
-
Vieira, J.,
and Messing, J.
(1987)
Methods Enzymol.
153,
3-11[Medline]
[Order article via Infotrieve]
-
Miller, J. H.
(1992)
A Short Course in Bacterial Genetics: A Laboratory Manual and Handbook for Escherichia coli and Related Bacteria, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
-
Saier, M. H., Jr.,
and Roseman, S.
(1972)
J. Biol. Chem.
247,
972-975[Abstract/Free Full Text]
-
Manayan, R.,
Tenn, G.,
Yee, H. B.,
Desai, J. D.,
Yamada, M.,
and Saier, M. H., Jr.
(1988)
J. Bacteriol.
170,
1290-1296[Abstract/Free Full Text]
-
Matsudaira, P.
(1987)
J. Biol. Chem.
262,
10035-10038[Abstract/Free Full Text]
-
Maniatis, T.,
Fritsch, E. F.,
and Sambrook, J.
(1982)
Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
-
Sanger, F.,
Nicklen, S.,
and Coulson, A. R.
(1977)
Proc. Natl. Acad. Sci. U. S. A.
74,
5463-5467[Abstract/Free Full Text]
-
Yanisch-Perron, C.,
Vieira, J.,
and Messing, J.
(1985)
Gene (Amst.)
33,
103-119[CrossRef][Medline]
[Order article via Infotrieve]
-
Ameyama, M.,
Nonobe, M.,
Shinagawa, E.,
Matsushita, K.,
Takimoto, K.,
and Adachi, O.
(1986)
Agri. Biol. Chem.
50,
49-57
-
Dulley, J. R.,
and Grieve, P. A.
(1975)
Anal. Biochem.
64,
136-141[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. Mustafa, C. T. Migita, Y. Ishikawa, K. Kobayashi, S. Tagawa, and M. Yamada
Menaquinone as Well as Ubiquinone as a Bound Quinone Crucial for Catalytic Activity and Intramolecular Electron Transfer in Escherichia coli Membrane-bound Glucose Dehydrogenase
J. Biol. Chem.,
October 17, 2008;
283(42):
28169 - 28175.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Mustafa, Y. Ishikawa, K. Kobayashi, C. T. Migita, M. D. Elias, S. Nakamura, S. Tagawa, and M. Yamada
Amino Acid Residues Interacting with Both the Bound Quinone and Coenzyme, Pyrroloquinoline Quinone, in Escherichia coli Membrane-bound Glucose Dehydrogenase
J. Biol. Chem.,
August 8, 2008;
283(32):
22215 - 22221.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
MD. Elias, S. Nakamura, C. T. Migita, H. Miyoshi, H. Toyama, K. Matsushita, O. Adachi, and M. Yamada
Occurrence of a Bound Ubiquinone and Its Function in Escherichia coli Membrane-bound Quinoprotein Glucose Dehydrogenase
J. Biol. Chem.,
January 23, 2004;
279(4):
3078 - 3083.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
MD. Elias, M. Tanaka, M. Sakai, H. Toyama, K. Matsushita, O. Adachi, and M. Yamada
C-terminal Periplasmic Domain of Escherichia coli Quinoprotein Glucose Dehydrogenase Transfers Electrons to Ubiquinone
J. Biol. Chem.,
December 14, 2001;
276(51):
48356 - 48361.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Nitta, H. Nagamitsu, M. Murata, H. Izu, and M. Yamada
Function of the sigma E Regulon in Dead-Cell Lysis in Stationary-Phase Escherichia coli
J. Bacteriol.,
September 15, 2000;
182(18):
5231 - 5237.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M D. Elias, M. Tanaka, H. Izu, K. Matsushita, O. Adachi, and M. Yamada
Functions of Amino Acid Residues in the Active Site of Escherichia coli Pyrroloquinoline Quinone-Containing Quinoprotein Glucose Dehydrogenase
J. Biol. Chem.,
March 15, 2000;
275(10):
7321 - 7326.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|